PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.36 +0.01 (+2.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Cost of Revenue (2010 - 2012)

Updated

PharmaCyte Biotech's Cost of Revenue was $9,620 in FY2013 (year ended Apr 30, 2013), down 50.4% from $19,383 in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Cost of Revenue (2010 - 2012) Analysis & Trends

  • Per Business Quant data, Cost of Revenue in earlier fiscal years was $19,383 in FY2012 (-39.6%) and $32,104 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 PharmaCyte Biotech 3.86 Mn -68.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 9,620.00
Apr 30, 2012 -4,539.00
Jan 31, 2012 2,211.00
Oct 31, 2011 6,036.00
Jul 31, 2011 15,675.00
Apr 30, 2011 343.00
Jan 31, 2011 21,980.00
Oct 31, 2010 2,854.00
Jul 31, 2010 6,927.00
API Access

PharmaCyte Biotech Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PMCB&period=max&api_key=YOUR_API_KEY